Since 1974, ABEC has been a leader in delivering customized single-use, stainless steel, and hybrid solutions and services for manufacturing in the biopharmaceutical industry. A majority of the world’s pharmaceutical and biotech companies are ABEC customers, with many of today’s leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. ABEC’s unique value is based on long experience, complete in-house capabilities, a customized, flexible approach, and long-term credibility. Whether adding capacity or improving existing operations ABEC’s turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity.
Find locations served, office locations
- Business Type:
- Service provider
- Industry Type:
- Market Focus:
- Globally (various continents)
- Year Founded:
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
INDUSTRY LEADING CAPACITY, GLOBAL CAPABILITY
ABEC’s North American manufacturing facilities, Springfield, MO, and Bethlehem, PA, are members of the Safety and Health Achievement Recognition Program (SHARP) of the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA). As the only supplier of bioprocess systems to achieve SHARP status, ABEC joins an elite group of businesses recognized for their worksite safety and health program. Read more about ABEC’s SHARP certification.
45+ YEARS MANUFACTURING AND DELIVERING THE COMPLETE BIOPROCESS
ABEC was founded at the dawn of the Biotech Era and has been an innovation leader in bioprocess engineering and equipment design ever since. Prior to the 1990’s ABEC developed numerous improvements in systems design, materials and finishes, Clean-in-Place/Steam-in-Place (CIP/SIP) integration, sterile agitator seals, sanitary component design, mixing and mass transfer, documentation, and automation. Since that time, our spirit of leadership in innovation continues as we further develop our products, services and global infrastructure. Strategic investments reinvent our ability to deliver integrated bioprocess solutions and services on a global scale.